Sökning: "oral anticoagulants"

Visar resultat 16 - 20 av 34 avhandlingar innehållade orden oral anticoagulants.

  1. 16. Studies on antibodies against phospholipids

    Författare :Leopold Årfors; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :Antiphospholipid syndrome; anticardiolipin antibodies; lupus anticoagulants; platelets; platelet activation; complement activation; endothelial cells; thromboxane; prostacyclin; acetylsalicylic acid.;

    Sammanfattning : The main clinical features of the antiphospholipid syndrome (APLS) are arterial and venous thrombosis, repeated spontaneous abortions and thrombocytopenia. Diagnosed concomitant with an underlying disease the designation is secondary APLS; otherwise primary APLS. LÄS MER

  3. 17. Anticoagulant and antiarrhythmic agents for atrial fibrillation

    Författare :Natalia Mochalina; Malmö Klinisk koagulationsmedicin; []
    Nyckelord :;

    Sammanfattning : Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. AF treatment involves management of precipitating factors, rate- and rhythm control and anticoagulation for prevention of stroke and systemic thromboembolism. LÄS MER

  4. 18. Hip arthroplasty : infections, thromboembolic events and surgical environment

    Författare :Piotr Kasina; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :;

    Sammanfattning : Background: Each year hip arthroplasties increase the quality of life for over 1 million patients worldwide. Although the complication rates are low, the absolute numbers are rising as the numbers of procedures increase. LÄS MER

  5. 19. Atrial Fibrillation in the setting of Coronary Artery Disease : Risks and outcomes with different treatment options

    Författare :Gorav Batra; Jonas Oldgren; Gunnar Gislason; Uppsala universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; atrial fibrillation; coronary artery disease; acute coronary syndrome; myocardial infarction; percutaneous coronary intervention; coronary artery bypass grafting; antithrombotic therapy; angiotensin-converting enzyme inhibitors; angiotensin II receptor blockers; epidemiology; Medicinsk vetenskap; Medical Science;

    Sammanfattning : Coronary artery disease (CAD) is the leading cause of mortality worldwide and atrial fibrillation (AF) is a prevalent arrhythmia associated with increased risk of mortality and morbidity. Despite improved outcome in both diseases, there is a need to further describe the prevalence, outcome and management of CAD in patients with concomitant AF. LÄS MER

  7. 20. Clinical aspects on treatment of deep venous thrombosis with a low molecular weight heparin

    Författare :Margareta Holmström; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :;

    Sammanfattning : Dalteparin is a low molecular weight heparin (LMWH) with a mean mw of 4-6000 D. Compared to unfractionated heparin (UFH), a higher bioavailability, a longer half-life and a more predictable dose-response is achieved after subcutaneous injections. LÄS MER